Abiopharma

Palisade Bio Receives FDA Clearance of IND for PALI-2108 and Plans to Initiate Global Phase 2 ASCENTRA-UC Study in Ulcerative Colitis

HCA Healthcare - HCA Healthcare Announces New England Journal of Medicine Study Highlighting Advances in CRISPR-based Therapy for Children

Alto Ingredients, Inc. Added to Russell2000® and Russell 3000® Indexes

Achieve Life Sciences Joins Russell 2000® Index

Palisade Bio Receives FDA Clearance of IND for PALI-2108 and Plans to Initiate Global Phase 2 ASCENTRA-UC Study in Ulcerative Colitis

Patriot Bank Opens Flagship California Location in Beverly Hills With Over $100 Million in Deposits

Approval from Health Canada to expand Serenta Registrational Phase 3 trial in FAP and Update on Serenta Progress

Achieve Life Sciences Joins Russell 2000® Index

Evommune Announces Top-line Results from EVO756 Phase 2b Trial in Moderate-to-Severe Chronic Spontaneous Urticaria

Mingteng International Reaches New Milestone in Global Expansion with Overseas Orders Serving Markets in Serbia, Vietnam and Mexico